Status:
RECRUITING
Patient's Whole Process Follow-up Management(HOPE-1)
Lead Sponsor:
Qianfoshan Hospital
Conditions:
Locally Advanced Non-Small Cell Lung Cancer
Metastatic NSCLC
Eligibility:
All Genders
18+ years
Brief Summary
Our project is going to explore whether management and follow-up of locally advanced/metastatic patients using the patient process management platform can prolong patient survival and improve patient ...
Detailed Description
Now, the treatment of NSCLC is diversiform, such as radiation and chemotherapy, targeted therapy, immune therapy, the treatment goal is to reduce symptoms, improve quality of life, prolong life. But a...
Eligibility Criteria
Inclusion
- Fully understand the research and voluntarily sign the informed consent form (ICF)
- Male or female subjects who are over 18 years old (inclusive) at the time of signing the informed consent form.
- The subject is diagnosed pathologically or cytologically with non-small cell lung cancer(NSCLC).
- According to the 8th edition of the American Joint Committee on Cancer \[AJCC\], it is classified as stage IIB, stage III, stage IV NSCLC.
- Not suitable for radical treatment or refuse surgery.
- The life expectancy is not less than 3 months.
- Be able to use a smartphone.
Exclusion
- Patients with mental illness.
- Presence of any other malignant tumor.
- Patients who are expected to undergo radical surgery.
- Currently participating in clinical trials.
- Subjects who judged by the investigator to be unsuitable to participate in the trial.
Key Trial Info
Start Date :
May 22 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 20 2030
Estimated Enrollment :
1268 Patients enrolled
Trial Details
Trial ID
NCT05339568
Start Date
May 22 2022
End Date
August 20 2030
Last Update
September 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Shandong First Medical University
Jinan, Shandong, China